Mutual Benefits Assurance (NSA:MBAS) Research & Development: ₦0.00 Mil (TTM As of Dec. 2025)


NSA:MBAS Mutual Benefits Assurance PLC NSA:MBAS
59 GF Score
Price ₦3.84
GF Value ₦2.25
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Mutual Benefits Assurance Research & Development?

Mutual Benefits Assurance NSA:MBAS +5.21% 59 Research & Development is ₦0.00 Mil as of Dec. 2025. GuruFocus rates NSA:MBAS with a GF Score™ of 59/100 and a GF Value™ of ₦2.25 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Mutual Benefits Assurance's Research & Development for the three months ended in Dec. 2025 was ₦0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was ₦0.00 Mil.

Mutual Benefits Assurance  (NSA:MBAS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mutual Benefits Assurance Research & Development Related Terms

Mutual Benefits Assurance Research & Development Historical Data

* Premium members only.

The historical data trend for Mutual Benefits Assurance's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mutual Benefits Assurance Research & Development Chart

Mutual Benefits Assurance Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Mutual Benefits Assurance Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSA:MBAS
59GF Score
Mutual Benefits Assurance PLC NSA:MBAS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mutual Benefits Assurance Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₦0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₦0.00 Mil mean?
Mutual Benefits Assurance (NSA:MBAS) has a Research & Development of ₦0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Mutual Benefits Assurance and its competitors.
Is Mutual Benefits Assurance's Research & Development too high?
Mutual Benefits Assurance's current Research & Development is ₦0.00 Mil. Overall, Mutual Benefits Assurance has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mutual Benefits Assurance's Research & Development compare to BRK.A and AIG?
Mutual Benefits Assurance's Research & Development of ₦0.00 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Mutual Benefits Assurance and its competitors. Mutual Benefits Assurance's current Research & Development is ₦0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mutual Benefits Assurance stock overvalued right now?
Based on GuruFocus' analysis, Mutual Benefits Assurance (NSA:MBAS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₦2.25, compared to a current price of ₦3.84 — trading 70.7% above its estimated fair value. The current Research & Development is ₦0.00 Mil. Mutual Benefits Assurance's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Mutual Benefits Assurance (NSA:MBAS), the current Research & Development is ₦0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mutual Benefits Assurance (NSA:MBAS) Overvalued in 2026?

Based on GuruFocus' analysis, Mutual Benefits Assurance stock appears to be overvalued. The current stock price of ₦3.84 is trading 70.7% above its estimated GF Value™ of ₦2.25. GuruFocus considers Mutual Benefits Assurance to be Significantly Overvalued.

Key valuation signals for NSA:MBAS:

  • Research & Development: ₦0.00 Mil
  • GF Value™: ₦2.25 vs. price of ₦3.84 (70.7% above fair value)
  • GF Score™: 59/100 with 1 warning sign

No single metric tells the full story. See the NSA:MBAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mutual Benefits Assurance Business Description

Address 233 Ikorodu Road, Aret Adams House, Ilupeju, Lagos, NGA
Mutual Benefits Assurance PLC is a financial and wealth protection company in Nigeria. The principal objective of the Company is to render qualitative life related insurance & risks management services. It is a premium provider of life insurance, annuity and investment products and services. It has four reportable operating segments; assurance business, real estate, microfinance bank, and oil and gas exploration and production. The majority of revenue comes from Assurance business which covers the protection of customers' assets (Particularly their properties, both for personal and commercial business) and indemnification of other parties that have suffered damage as a result of customers accident. It has presence in Nigeria, and Liberia.
59GF Score

Get the complete analysis for NSA:MBAS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₦3.84
Price
₦2.25
GF Value